Are Steatosis and Steatohepatitis Triggers of Hepatic Fibrogenesis?
Journal Title: Гастроентерологія - Year 2013, Vol 2, Issue 48
Abstract
The article displays current views on the process of fibrogenesis in patients with fatty liver disease. It is shown that steatosis and steatohepatitis are the main triggers of the process of fibrogenesis. Modern mechanisms of hepatic fibrosis were described. The issues of reversibility of fibrosis in liver diseases, particularly in fatty liver disease, are discussed. The main directions of antifibrotic therapy are shown. Administration of essential phospholipids in patients with hepatic steatosis and steatohepatitis with signs of fibrosis is appropriate from the perspective of evidence-based medicine. Enerliv® is a new generation of hepatoprotectors, it consists of fat-free soy phospholipids with a maximum degree of purity, and the concentration of phosphatidylcholine is an average of 76 % — a parameter unattainable for most preparations of essential phospholipids present in the domestic pharmaceutical market. Diffuse liver disease include membrane-associated defects and can proceed with the development of fibrosis, so the administration of phospholipids in a preparation Enerliv® can be considered as a basic therapy for fatty liver disease.
Authors and Affiliations
Yu. M. Stepanov, О. Yu. Filippova
Keywords
Related Articles
- EP ID EP229989
- DOI -
- Views 76
- Downloads 0
The Mechanisms of Development and Approaches to the Treatment of Sphincter of Oddi Dysfunction after Cholecystectomy
The paper considers sphincter of Oddi dysfunction in the patients after cholecystectomy. There are described the pathogenesis and clinical manifestations of this pathology as well as the items on its therapy. The usage o...
Influence of Concomitant Gastroesophageal Reflux Disease on Clinical Course and Respiratory Function in Patients with Chronic Obstructive Pulmonary Disease
The main clinical features of clinical course of comorbidity are shown in the article. The value of estimating functional changes of spirogram in these patients is described. The role of concomitant gastroesophageal refl...
Characteristics of changes in lipid and carbohydrate metabolism indices in patients with morbid obesity before and after surgical treatment depending on the type of surgical intervention
Background. Obesity is a chronic metabolic disease that is manifested by excessive development of adipose tissue, which has a certain range of complications and a high risk of relapse after the end of treatment. The asso...
Clinical and Epidemiological Features of Hepatitis among the Residents of the Transcarpathian Region
The clinical and epidemiological features of hepatitis A in the Transcarpathian region for years 2004–2014 were indicated. A specific cyclicism and seasonality of hepatitis A in this region of Ukraine was established. Ba...
Proton Pump Inhibitors and Risk of Drug Interactions
In the article, the current data regarding drug interactions of proton pomp inhibitors (PPI) with other preparations are discussed. It is concluded that the risk of adverse drug interactions is enhanced by the use of PPI...